Growth Metrics

Boston Scientific (BSX) Other Non-Current Liabilities (2016 - 2026)

Boston Scientific's Other Non-Current Liabilities history spans 18 years, with the latest figure at $2.5 billion for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 26.88% to $2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 billion, a 26.88% increase, with the full-year FY2025 number at $2.4 billion, up 28.61% from a year prior.
  • Other Non-Current Liabilities hit $2.5 billion in Q1 2026 for Boston Scientific, up from $2.4 billion in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BSX hit a ceiling of $2.5 billion in Q1 2026 and a floor of $1.8 billion in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: decreased 16.55% in 2022 and later surged 32.39% in 2025.
  • Tracing BSX's Other Non-Current Liabilities over 5 years: stood at $2.0 billion in 2022, then dropped by 3.34% to $2.0 billion in 2023, then dropped by 4.93% to $1.9 billion in 2024, then increased by 28.61% to $2.4 billion in 2025, then rose by 2.66% to $2.5 billion in 2026.
  • Business Quant data shows Other Non-Current Liabilities for BSX at $2.5 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.